Original Article
Impact of age and gender on adherence to infection control guidelines and medical regimens in cystic fibrosis†
Tracy Loye Masterson PhD,
Beth G. Wildman PhD, Benjamin H. Newberry PhD, Gregory J. Omlor MD,
Corresponding Author
Tracy Loye Masterson PhD
John Carroll University, University Heights, Ohio
John Carroll University, 20700 North Park Boulevard, University Heights, OH 44118.Search for more papers by this authorTracy Loye Masterson PhD,
Beth G. Wildman PhD, Benjamin H. Newberry PhD, Gregory J. Omlor MD,
Corresponding Author
Tracy Loye Masterson PhD
John Carroll University, University Heights, Ohio
John Carroll University, 20700 North Park Boulevard, University Heights, OH 44118.Search for more papers by this author†
Site of primary data collection from Akron Children's Hospital.
Abstract
Rationale
The goal of the present research was to examine the impact of age and gender on adherence to both infection control (IC) guidelines and traditional medical treatments in a cystic fibrosis (CF) population. Adherence behaviors are consistently suboptimal in chronic illness populations, particularly pulmonary diseases; understanding the factors related to adherence behaviors in CF can aid in the development of interventions to promote adherence.
Method
Participants consisted of 74 individuals with CF ages 9 years and above. Participants were asked to complete questionnaires designed to assess demographic data, treatment adherence, and health beliefs.
Results
With respect to IC guidelines, chi-square analyses revealed significant age differences in adherence behaviors such that the young adult subsample was least adherent to IC (χ2 = 15.10, df = 6, P = 0.020). Next, a 4 (age: child, adolescent, young adult, adult) × 2 (gender) completely between subjects analysis of variance (ANOVA) was conducted on medical treatment adherence. There was a significant main effect for age [F(3, 65) = 2.940, P = 0.040, ηP2 = 0.119] indicating that the adolescent subsample had the most adherence challenges. Gender was nonsignificant across both adherence types.
Conclusions
Study findings are suggestive of age-related differences in adherence behaviors across both IC and medical regimens and support the use of developmentally sensitive approaches to assessment and interventions addressing adherence. Pediatr Pulmonol. 2011; 46:295–301. © 2011 Wiley-Liss, Inc.
Supporting Information
Additional Supporting information may be found in the online version of this article.
| Filename | Description |
|---|---|
| ppul_21366_sm_suppQueAd.doc35 KB | Supplementary Demographic Questionnaire (Adult) |
| ppul_21366_sm_suppQuePar.doc32 KB | Supplementary Demographic Questionnaire (Parent) |
| ppul_21366_sm_suppQueRevParentVersion.doc66.5 KB | Supplementary Health Belief Model Scale -Revised (Parent Version) |
| ppul_21366_sm_RevPatientVersion.doc75 KB | Supplementary Health Beliefs Model Scale -Revised (Patient Version) |
| ppul_21366_sm_CysticFibrosisParentVersion.doc30.5 KB | Supplementary Self Care Inventory - Cystic Fibrosis (Parent Version) |
| ppul_21366_sm_CysticFibrosisPatientVersion.doc29.5 KB | Supplementary Self Care Inventory - Cystic Fibrosis (Patient Version) |
| ppul_21366_sm_CysticFibrosisPhysicianVersion.doc30 KB | Supplementary Self Care Inventory - Cystic Fibrosis (Physician Version) |
| ppul_21366_sm_ImpactAge.doc24 KB | Supplementary Impact of Age and Gender on Adherence to Infection Control Guidelines and Medical Regimens in Cystic Fibrosis |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Cystic Fibrosis Foundation: Patient Registry 2007. Bethesda, MD: Cystic Fibrosis Foundation Annual Report, 2008.
- 2 M Bluebond-Langner, B Lask, DB Angst, editors. Psychosocial aspects of cystic fibrosis. New York: Oxford University Press; 2001.
- 3 Saiman L, Siegel J. The Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol (Suppl) 2003; 24: 6–52.
- 4 Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertso CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138: 699–704.
- 5 Cystic Fibrosis Foundation: Patient Registry 2007. Besthesda, MD: Cystic Fibrosis Foundation Annual Report, 2008.
- 6 Govan JR, Brown OH, Maddison J, Doherty JW, Nelson M, Dodd AP, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15–19.
- 7
Ojeniyi B,
Frederiksen B,
Hoiby N.
Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.
Pediatr Pulmonol
2000;
29:
177–181.
10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U CAS PubMed Web of Science® Google Scholar
- 8 Zuckerman JB, Zuaro DE, Prato BS, Ruoff KL, Sawicki RW, Quinton HB, Saiman L. Bacterial contamination in cystic fibrosis clinic. J Cyst Fibros 2009; 8: 186–192.
- 9 Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Taccetti G, Mastella G. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: A systematic review. J Hosp Infect 2006; 64: 1–6.
- 10 Cystic Fibrosis Foundation: Patient Registry 2004. Besthesda, MD: Cystic Fibrosis Foundation Annual Report, 2005.
- 11 Griffiths AL, Armstrong D, Carzino R, Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J 2004; 24: 449–452.
- 12 Masterson TL, Wildman BG, Newberry B, Omlor GM, Bryson E, Kukay A. Compliance in cystic fibrosis: an examination of infection control guidelines. Pediatr Pulmonol 2008; 43: 435–442.
- 13 Ullrich G, Wiedau S, Schultz W, Steinkamp G. Parental knowledge and behaviour to prevent environmental P. aeruginosa acquisition in their children with CF. J Cyst Fibros 2008; 7: 231–237.
- 14 Garber E, Desai M, Zhou J, Alba L, Angst D, Cabana M, Saiman L. Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol 2008; 43: 900–907.
- 15 Rapoff M, Christophersen E. Compliance of pediatric patients with medical regimens: a review and evaluation. In: R Stuart, editor. Adherence, compliance and generalization in behavioral medicine. New York: Brunner/Mazel; 1982. pp. 79–124.
- 16 White D, Stiller K, Haensel N. Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens. J Cyst Fibros 2007; 6: 163–170.
- 17 Myers LB, Horn SA. Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006; 11: 915–926.
- 18 Drotar D, Ievers C. Age differences in parent and child responsibilities for management of cystic fibrosis and insulin-dependent diabetes mellitus. Dev Behav Pediatr 1994; 15: 265–272.
- 19 Wysocki T, Taylor A, Hough B, Linscheid TR, Yeates KO, Naglieri JA. Deviation from developmentally appropriate self-care autonomy: associations with diabetes outcomes. Diabetes Care 1996; 19: 119–125.
- 20
Geiss SK,
Hobbs SA,
Hammerley-Maercklein G,
Kramer JC,
Henley M.
Psychosocial factors related to perceived compliance in cystic fibrosis treatments.
J Clin Psychol
1992;
48:
99–103.
10.1002/1097-4679(199201)48:1<99::AID-JCLP2270480114>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- 21 Ricker JH, Delamater AM, Hsu J. Correlates of regimen adherence in cystic fibrosis. J Clin Psychol Med Sch 1998; 5: 159–172.
- 22
Tebbi CK,
Cummings M,
Zevon MA,
Smith L,
Richards M,
Mallon J.
Compliance of pediatric and adolescent cancer patients.
Cancer
1986;
58:
1179–1184.
10.1002/1097-0142(19860901)58:5<1179::AID-CNCR2820580534>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 23 Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. Dev Behav Pediatr 1991; 12: 236–242.
- 24 Hamutcu R, Rowland JM, Horn MV, Kaminsky C, McLaughlin EF, Starnes VA, Woo MS. Clinical findings and lung pathology in children with cystic fibrosis. Am J Resp Crit Care 2002; 165: 1172–1175.
- 25 Hegarty M, Macdonald J, Watter P, Wilson C. Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions. Child Care Health Dev 2009; 35: 462–468.
- 26 Reis HT, Collins WA, Berscheid E. The relationship context of human behavior and development. Psychol Bull 2000; 126: 844–872.
- 27 Czajkowski DR, Koocher GP. Medical compliance and coping with cystic fibrosis. J Child Psychol Psychiatry 1987; 28: 311–319.
- 28 Patterson JM, Wall M, Berge J, et al. Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire. J Cyst Fibros 2008; 7: 154–164.
- 29 Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794–803.
- 30 Willis E, Miller R, Wyn J. Gender embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001; 53: 1163–1174.
- 31 Berndt TJ. The features and effects of friendship in early adolescence. Child Dev 1982; 53: 1447–1460.
- 32 La Greca AM, Swales T, Klemp S, Madigan S, Skyler J. Self-care behaviors among adolescents with diabetes. 9th Annual Sessions of the Society of Behavioral Medicine, Baltimore, MD; 1988.
- 33 Champion VL. Instrument development for health belief model constructs. Adv Nurs Sci 1984; 6: 73–85.
- 34 Grol R. National standard setting for quality of care in general practice: attitudes of general practitioners and response to a set of standards. Br J Gen Pract 1990; 40: 361–364.
- 35 DiGirolamo AM, Quittner AL, Ackerman V, Stevens J. Identification and assessment of ongoing stressors in adolescents with a chronic illness: an application of the Behavior Analytic Model. J Clin Psychol 1997; 26: 53–66.
- 36 Kyngäs HA, Kroll T, Duffy ME. Compliance in adolescence with chronic diseases: a review. J Adolesc Health 2000; 26: 379–388.
- 37 Elkind D. Egocentrism in adolescence. Child Dev 1967; 38: 1025–1034.
- 38 Naar-King S, Idalski A, Ellis D, Frey M, Templin T, Cunningham PB, Cakan N. Gender differences in adherence and metabolic control in urban youth with poorly controlled type 1 diabetes: the mediating role of mental health symptoms. J Pediatr Psychol 2006; 31: 793–802.
- 39 Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Int Med 2004; 19: 1111–1117.
- 40 Strecher VJ, Rosenstock LM. The health belief model. In: K Glanz, F Lewis, BK Rimer, editors. Health behavior and health education: theory, research & practice, 2nd edition. San Francisco, CA: Jossey-Bass; 1996. pp. 41–59.
- 41 Rosenstock IM. The health belief model and preventative health behavior. Health Educ Monogr 1974; 2: 354–386.
- 42 Quittner AL, Drotar D, Ievers-Landis C. Adherence to medical treatments in individuals with cystic fibrosis: the development and evaluation of family-based interventions. In: D Drotar, editor. Promoting adherence to medical treatments in chronic illness: concepts, methods, and interventions. Mahwah, NJ: Lawrence Erlbaum Associates; 2000. pp. 393–407.
- 43 Flume PA, Anderson DL, Hardy KK, Gray S. Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors. Pediatr Pulmonol 2001; 31: 443–450.
- 44 Burroughs TE, Pontious SL, Santiago JV. The relationship among six psychosocial domains, age, health care adherence, and metabolic control in adolescents with IDDM. Diab Educ 1993; 19: 396–402.
- 45 Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol 2009; 45: 157–164.
Citing Literature
